EAST RUTHERFORD, N.J., April 26, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM) announced that first quarter 2016 financial results will be released on Friday, April 29, 2016 before the market opens.
The Company will host a conference call to discuss the financial results.
First Quarter 2016 Earnings Conference Call
When: Friday, April 29, 2016 at 8:30 a.m. Eastern Time
Dial-in: 1-800-768-6544 for U.S.
1-785-830-7990 for International
Dial-in Replay: 1-888-203-1112 for U.S.
1-719-457-0820 for International
Available through Friday, May 6, 2016
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.
Contact: Stephanie LaFiura Investor Relations Associate Phone: 201.804.3037 Email: firstname.lastname@example.org